Lilly's Mounjaro (tirzepatide) receives UK marketing authorisation for weight management
Eli Lilly and Company has granted marketing authorisation (MA) by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for...
top of page
Browse by category
Search
FDA clears GE HealthCare’s Allia IGS Pulse next generation of image-guided systems
GE HealthCare has gained FDA 510(k) clearance of the Allia IGS Pulse - the latest addition to the company’s image guided system (IGS)...
Rhythm gains Health Canada Approval of IMCIVREE setmelanotide injection for weight management
Health Canada has approved Rhythm Pharmaceuticals’ IMCIVREE (setmelanotide solution for subcutaneous injection) for weight management in...
Endolumik gains FDA approval for fluorescence guided Gastric Calibration Tube
Endolumik’s fluorescence guided Gastric Calibration Tube, which uses near infrared (NIR) light to allow surgeons to more clearly...
NICE recommends semaglutide should be made available in specialist NHS services
The UK’s regulatory body, NICE, has recommended the use of semaglutide (also called Wegovy or Ozempic) alongside a reduced-calorie diet...
ReShape Lifesciences’ GIBI HD Calibration Tubes approved by FDA
ReShape Lifesciences has received FDA 510(k) clearance for the disposable, Gastro Intestinal Balloon Indicator (GIBI HD) calibration tube...
Saxenda approved for the treatment of obesity in adolescents
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a licence extension for Saxenda (Novo Nordisk) for the...
Standard Bariatrics’ Titan SGS Stapling Technology for LSG gains FDA approval
Standard Bariatrics has announced that its novel Titan SGS stapling technology, designed specifically for bariatric sleeve surgery, has...
TransEnterix gains CE Mark for machine vision system in robotic surgery
TransEnterix has received CE Mark approval for the Intelligent Surgical Unit (ISU) that enables machine vision capabilities on the...
FDA approves Saxenda for the treatment of obesity in adolescents
Novo Nordisk has received FDA approval for an updated label for Saxenda (liraglutide) injection 3mg for use in the treatment of obesity...
Browse by tag
bottom of page